Financial Ratios

PHARMACIA HEALTHCARE LTD. (MERGED)

NSE : NABSE : 506817ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : MNC
BSE132.850 (0 %)
PREV CLOSE ( ) 132.85
OPEN PRICE ( ) 128.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )128.50 134.80
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsNov2003Dec2002Mar2002Mar2001Mar2000
Operational & Financial Ratios
   Earnings Per Share (Rs)-22.43-4.811.856.196.71
   CEPS(Rs)-19.63-3.303.887.974.78
   DPS(Rs)0.000.000.002.003.00
   Book NAV/Share(Rs)11.6466.5471.3572.09128.03
   Tax Rate(%)8.07-14.5135.7021.8512.24
Margin Ratios
   Core EBITDA Margin(%)-22.89-3.093.366.226.86
   EBIT Margin(%)-36.59-4.531.924.012.87
   Pre Tax Margin(%)-38.35-4.751.683.651.76
   PAT Margin (%)-35.25-5.441.082.851.54
   Cash Profit Margin (%)-30.85-3.732.263.672.20
Performance Ratios
   ROA(%)-24.16-5.241.905.993.40
   ROE(%)-57.39-6.982.599.108.95
   ROCE(%)-42.23-5.754.5011.8210.18
   Asset Turnover(x)0.690.961.762.102.21
   Sales/Fixed Asset(x)1.431.883.504.835.67
   Working Capital/Sales(x)3.522.134.255.475.20
Efficiency Ratios
   Fixed Capital/Sales(x)0.700.530.290.210.18
   Receivable days54.1057.7439.8741.3342.52
   Inventory Days135.32100.1553.6851.1943.87
   Payable days72.1956.3343.9355.2962.85
Valuation Parameters
   PER(x)0.000.00111.4425.6440.26
   PCE(x)-7.31-41.5453.2919.9256.43
   Price/Book(x)12.342.062.902.204.22
   Yield(%)0.000.000.001.260.56
   EV/Net Sales(x)2.971.711.200.761.36
   EV/Core EBITDA(x)-13.50-90.5727.8510.6017.28
   EV/EBIT(x)-7.44-34.5158.3717.9744.03
   EV/CE(x)1.801.542.051.542.61
   M Cap / Sales2.461.691.280.771.33
Growth Ratio
   Net Sales Growth(%)-28.06-49.71-21.721.4411.35
   Core EBITDA Growth(%)-740.29-122.07-53.03-7.4429.64
   EBIT Growth(%)-480.71-221.41-61.9939.03-1.65
   PAT Growth(%)-366.08-359.56-70.0484.61421.17
   EPS Growth(%)-366.08-359.56-70.04-7.70349.32
Financial Stability Ratios
   Total Debt/Equity(x)2.630.020.000.040.12
   Current Ratio(x)1.913.403.142.522.43
   Quick Ratio(x)0.921.812.031.391.36
   Interest Cover(x)-20.81-20.727.8911.302.57
   Total Debt/Mcap(x)0.210.010.000.020.03

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.